Dec 31, 2020

Xenon Pharmaceuticals Q4 2020 Earnings Report

Total Revenue
$5.15M
Previous year: $3.33M
+54.7%
EPS
-$0.34
Previous year: -$0.41
-17.1%
Gross Profit
-$9.82M
Cash and Equivalents
$45M
Free Cash Flow
-$13.9M
Total Assets
$189M

Xenon Pharmaceuticals

Xenon Pharmaceuticals